Comparison of the quantification precision of human short echo time 1H spectroscopy at 1.5 and 4.0 Tesla

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Magnetic Resonance in Medicine

• Publication date

  2000-08-01

• Fields of study

  Materials Science, Medicine, Physics, Engineering

• Identifiers
  DOI 10.1002/1522-2594(200008)44:2<185::AID-MRM4>3.0.CO;2-VPMID 10918316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spectroscopic lineshape correction by QUECC: Combined QUALITY deconvolution and eddy current correction

  2000cited by this paper
• Proton MRS in neurological disorders.

  1999cited by this paper
• Factors affecting the quantification of short echo in‐vivo 1H MR spectra: prior knowledge, peak elimination, and filtering

  1999influential reference
• Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain.

  1999cited by this paper
• Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders.

  1999cited by this paper
• Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain.

  1998cited by this paper
• New approach for quantitation of short echo time in vivo 1H MR spectra of brain using AMARES

  1998cited by this paper
• Resolution improvements in in vivo 1H NMR spectra with increased magnetic field strength.

  1998cited by this paper
• Biological and clinical MRS at ultra‐high field

  1997cited by this paper
• In vivo measurement of T2 distributions and water contents in normal human brain

  1997cited by this paper
• Clinical Applications of Magnetic Resonance Spectroscopy

  1997cited by this paper
• MR relaxation times in human brain: measurement at 4 T.

  1996cited by this paper
• The relation between brain iron and NMR relaxation times: An in vitro study

  1996cited by this paper
• Nuclear Magnetic Resonance: Concepts and Methods

  1996cited by this paper
• An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients.

  1996cited by this paper
• Estimation of the iron concentration in excised gray matter by means of proton relaxation measurements

  1996cited by this paper
• The use of a priori knowledge to quantify short echo in vivo 1h mr spectra

  1995influential reference
• Anomalous Transverse Relaxation in 1H Spectroscopy in Human Brain at 4 Tesla

  1995influential reference
• Clinical applications of magnetic resonance spectroscopy.

  1994cited by this paper
• Time and frequency domain analysis of NMR data compared: An application to 1D 1H spectra of lipoproteins

  1994cited by this paper
• Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T

  1994cited by this paper
• Analysis of macromolecule resonances in 1H NMR spectra of human brain

  1994cited by this paper
• In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard.

  1993cited by this paper
• Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference

  1993cited by this paper
• Absolute Quantitation of Water and Metabolites in the Human Brain. II. Metabolite Concentrations

  1993cited by this paper
• Estimation of metabolite concentrations from localized in vivo proton NMR spectra

  1993cited by this paper
• Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra.

  1993cited by this paper
• Analysis of NMR Data Using Time Domain Fitting Procedures

  1992cited by this paper
• Improvements in localized proton NMR spectroscopy of human brain. Water suppression, short echo times, and 1 ml resolution

  1990cited by this paper
• In vivo proton spectroscopy in presence of eddy currents

  1990influential reference
• Quality: quantification improvement by converting lineshapes to the lorentzian type

  1990cited by this paper
• High field localized proton spectroscopy in small volumes: greatly improved localization and shimming using shielded strong gradients

  1989cited by this paper
• Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites

  1989cited by this paper
• Spectroscopy and imaging with a 4 tesla whole‐body mr system

  1988cited by this paper
• Improved algorithm for noniterative time-domain model fitting to exponentially damped magnetic resonance signals

  1987cited by this paper
• Error theory for time-domain signal analysis with linear prediction and singular value decomposition

  1986cited by this paper
• The field dependence of NMR imaging. II. Arguments concerning an optimal field strength

  1986cited by this paper
• Retrieval of frequencies, amplitudes, damping factors, and phases from time-domain signals using a linear least-squares procedure

  1985cited by this paper
• An Algorithm for Least-Squares Estimation of Nonlinear Parameters

  1963cited by this paper

• Magnetic Resonance Spectroscopy (MRS) transforming multiple sclerosis (MS) diagnosis

  2025cites this paper
• Relationship between GABA-Ergic System and the Expression of Mephedrone-Induced Reward in Rats—Behavioral, Chromatographic and In Vivo Imaging Study

  2023cites this paper
• Longitudinal cognitive function and brain metabolites in women receiving chemotherapy for stage 1 to 3 breast cancer: Observational study

  2023cites this paper
• Quantification of the neurochemical profile of the human putamen using STEAM MRS in a cohort of elderly subjects at 3 T and 7 T: Ruminations on the correction strategy for the tissue voxel composition

  2023cites this paper
• Repetitive mild traumatic brain injury in mice triggers a slowly developing cascade of long-term and persistent behavioral deficits and pathological changes

  2021cites this paper
• Terminology and concepts for the characterization of in vivo MR spectroscopy methods and MR spectra: Background and experts' consensus recommendations

  2020cites this paper
• On the acquisition of the water signal during water suppression: High‐speed MR spectroscopic imaging with water referencing and concurrent functional MRI

  2020cites this paper
• Transcranial direct current stimulation (tDCS) over the auditory cortex modulates GABA and glutamate: a 7 T MR-spectroscopy study

  2020cites this paper
• Neurometabolites and sport-related concussion: From acute injury to one year after medical clearance

  2020cites this paper
• Intra‐ and inter‐site reproducibility of human brain single‐voxel proton MRS at 3 T

  2019cites this paper
• Third Trimester Cerebellar Metabolite Concentrations are Decreased in Very Premature Infants with Structural Brain Injury

  2019cites this paper
• MRI Investigations of Metabolic and Structural Brain Changes in Alzheimer’s Disease and Vitamin D Deprivation

  2019influential citation
• Dorsal anterior cingulate cortex glutamate concentrations and their relationships in adults with autism spectrum disorder

  2018cites this paper
• Optimized in vivo brain glutamate measurement using long‐echo‐time semi‐LASER at 7 T

  2018cites this paper
• Comparison of reproducibility of single voxel spectroscopy and whole‐brain magnetic resonance spectroscopy imaging at 3T

  2018cites this paper
• Diurnal stability and long-term repeatability of neurometabolites using single voxel 1H magnetic resonance spectroscopy.

  2018cites this paper
• Test-retest reproducibility of neurochemical profiles with short-echo , single voxel MRS at 3 T and 7 T

  2017influential citation
• Effects of repeated dizocilpine treatment on glutamatergic activity in the prefrontal cortex in an animal model of schizophrenia: An in vivo proton magnetic resonance spectroscopy study at 9.4T.

  2017cites this paper
• MRS studies of neuroenergetics and glutamate/glutamine exchange in rats: Extensions to hyperammonemic models.

  2017cites this paper
• An investigation into the importance of T2 relaxation and echo time choice for accurate metabolite biomarker quantification

  2017influential citation
• Test‐retest reproducibility of neurochemical profiles with short‐echo, single‐voxel MR spectroscopy at 3T and 7T

  2016cites this paper
• Resting and Functional Magnetic Resonance Spectroscopy of Glutamate in Schizophrenia at 7 Tesla

  2015cites this paper
• The separation of Gln and Glu in STEAM: a comparison study using short and long TEs/TMs at 3 and 7 T

  2015cites this paper
• Semi‐LASER 1H MR spectroscopy at 7 Tesla in human brain: Metabolite quantification incorporating subject‐specific macromolecule removal

  2015cites this paper
• Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts

  2015cites this paper
• In Vivo Brain Magnetic Resonance Spectroscopy: A Measurement of Biomarker Sensitivity to Post-Processing Algorithms

  2014cites this paper
• Investigating Cortical Changes in Cervical Spondylotic Myelopathy Using Functional Magnetic Resonance Imaging, Proton Magnetic Resonance Spectroscopy and Diffusion Tensor Imaging

  2014cites this paper
• Reduced N-Acetylaspartate to Creatine Ratio in the Posterior Cingulate Correlates with Cognition in Alzheimer's Disease following Four Months of Rivastigmine Treatment

  2014cites this paper
• Magnetic Resonance Spectroscopy Investigations of Alzheimer Disease

  2014cites this paper
• Is the macromolecule signal tissue‐specific in healthy human brain? A 1H MRS study at 7 tesla in the occipital lobe

  2014cites this paper
• Neural brain activation imaging

  2014cites this paper
• Advances in High-Field Magnetic Resonance Spectroscopy in Alzheimer’s Disease

  2014cites this paper
• Localized Proton Magnetic Resonance Spectroscopy of Mouse Brain In Vivo at High Magnetic Field Strength

  2014cites this paper
• Improved quantification precision of human brain short echo‐time 1H magnetic resonance spectroscopy at high magnetic field: A simulation study

  2014cites this paper
• Proton Magnetic Resonance Spectroscopy as a Probe into the Pathophysiology of Autism Spectrum Disorders (ASD): A Review

  2013cites this paper
• Real-time automated spectral assessment of the BOLD response for neurofeedback at 3 and 7T.

  2013cites this paper
• Systematic Regional Variations of GABA, Glutamine, and Glutamate Concentrations Follow Receptor Fingerprints of Human Cingulate Cortex

  2013influential citation
• Forebrain Deletion of the Vesicular Acetylcholine Transporter Results in Deficits in Executive Function, Metabolic, and RNA Splicing Abnormalities in the Prefrontal Cortex

  2013cites this paper
• Quantification of the neurochemical profile using simulated macromolecule resonances at 3 T

  2013cites this paper
• eal-time automated spectral assessment of the BOLD response for eurofeedback at 3 and 7 T

  2013influential citation
• Animal models and high field imaging and spectroscopy

  2013cites this paper
• Motor cortex and gait in mild cognitive impairment: a magnetic resonance spectroscopy and volumetric imaging study.

  2013cites this paper
• Advanced magnetic resonance techniques for evaluating white matter

  2013cites this paper
• Computerized MRS voxel registration and partial volume effects in single voxel 1H-MRS.

  2013cites this paper
• Proton magnetic resonance spectroscopy: technique for the neuroradiologist.

  2013cites this paper
• Indirect Effects of Elevated Body Mass Index on Memory Performance Through Altered Cerebral Metabolite Concentrations

  2012cites this paper
• Proton magnetic resonance spectroscopy of the motor cortex in cervical myelopathy.

  2012cites this paper
• New perspectives in glutamate and anxiety.

  2012cites this paper
• Handling Macromolecule Signals in the Quantification of the Neurochemical Profile

  2012cites this paper
• In vivo detection of GABA and glutamate with MEGA‐PRESS: Reproducibility and gender effects

  2011cites this paper
• MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY IN THE STUDY IN ADHD SYNDROME: A SHORT REVIEW.

  2011cites this paper
• Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia

  2011cites this paper
• MRS of Rodents at Ultra-High Fields

  2011cites this paper
• Applications of multi-nuclear magnetic resonance spectroscopy at 7T.

  2011cites this paper
• Influence of work shift on glutamic acid and gamma-aminobutyric acid (GABA): evaluation with proton magnetic resonance spectroscopy at 3T.

  2011cites this paper
• Reduced hippocampal glutamate in Alzheimer disease.

  2011cites this paper
• Glutamatergic Metabolites and Gray Matt er Losses in Schizophrenia: A Longitudinal Study Using In Vivo Proton Magnetic Resonance Spectroscopy

  2011cites this paper
• 1H-MRS at 4 Tesla in minimally treated early schizophrenia

  2010cites this paper
• Bipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy study.

  2010cites this paper
• In vivo 1H NMR spectroscopy of the human brain at 9.4 T: initial results.

  2010cites this paper
• In Vivo 1 H NMR Spectroscopy of the Human Brain at 9.4 Tesla: Initial Results

  2010cites this paper
• Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease.

  2010cites this paper
• Spectral resolution amelioration by deconvolution (SPREAD) in MR spectroscopic imaging

  2009cites this paper
• Changes in Cerebral Oxygen Consumption and High-Energy Phosphates During Early Recovery in Hypoxic-Ischemic Piglets: A Combined Near-Infrared and Magnetic Resonance Spectroscopy Study

  2009cites this paper
• Normal metabolite levels in the left dorsolateral prefrontal cortex of unmedicated major depressive disorder patients: a single voxel (1)H spectroscopy study.

  2009cites this paper
• Comparative test–retest reliability of metabolite values assessed with magnetic resonance spectroscopy of the brain. The LCModel versus the manufacturer software

  2009cites this paper
• A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging.

  2009cites this paper
• Differential Diagnosis of Brain Diseases Using In Vivo Proton Magnetic Resonance Spectroscopy at 3 Tesla: A Preliminary Study

  2009cites this paper
• Short echo time single voxel magnetic resonance spectoscopy in the characterisation of childhood brain tumours.

  2009cites this paper
• In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.

  2009cites this paper
• Molecular neurodevelopment: An in vivo31P-1H MRSI study

  2009cites this paper
• Myo‐Inositol: a marker of reactive astrogliosis in glial tumors?

  2008cites this paper
• Quantitative Bestimmung von Glutamat im Hirn mithilfe der MR-Protonenspektroskopie bei 1,5 T und 3 T

  2008cites this paper
• Spectral simplification for resolved glutamate and glutamine measurement using a standard STEAM sequence with optimized timing parameters at 3, 4, 4.7, 7, and 9.4T

  2008influential citation
• Arterial Spin Labeled Perfusion MRI

  2008cites this paper
• 3-T MRI with phased-array coil in local staging of prostatic cancer.

  2008cites this paper
• Quantitative proton magnetic resonance spectroscopy of the normal liver and malignant hepatic lesions at 3.0 Tesla

  2008cites this paper
• Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania.

  2008cites this paper
• Regional apparent metabolite concentrations in young adult brain measured by 1H MR spectroscopy at 3 Tesla

  2008cites this paper
• Advanced parallel magnetic resonance imaging methods with applications to MR spectroscopic imaging

  2008cites this paper
• Was bringt der 3-Tesla-MRT mehr?

  2008cites this paper
• High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.

  2008cites this paper
• INTRAMYOCELLULAR LIPID QUANTIFICATION: COMPARISON BETWEEN 3.0- AND 1.5-TESLA 1 H MR SPECTROSCOPY

  2008influential citation
• Simultaneous detection of resolved glutamate, glutamine, and gamma-aminobutyric acid at 4 T.

  2007cites this paper
• Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia

  2007influential citation
• Proton echo‐planar spectroscopic imaging of J‐coupled resonances in human brain at 3 and 4 Tesla

  2007cites this paper
• Reproducibility of magnetic resonance spectroscopy in correlation with signal-to-noise ratio.

  2007cites this paper
• Sustained Neuronal Activation Raises Oxidative Metabolism to a New Steady-State Level: Evidence from 1H NMR Spectroscopy in the Human Visual Cortex

  2007cites this paper
• Effect of signal‐to‐noise ratio and spectral linewidth on metabolite quantification at 4 T

  2007cites this paper
• Ethnic variations in the experiences of mental health service users in England

  2007cites this paper
• Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity.

  2007cites this paper
• Recent advances in magnetic resonance neurospectroscopy

  2007influential citation
• Intramyocellular lipid quantification: comparison between 3.0- and 1.5-T (1)H-MRS.

  2007cites this paper
• Torill Eidhammer Sjøbakk MR determined brain metabolic pattern in patients with brain metastases and adolescents with low birth weight

  2007cites this paper
• Simultaneous detection of resolved glutamate, glutamine, and γ-aminobutyric acid at 4 T

  2007cites this paper
• Quantitative short echo‐time 1H LASER‐CSI in human brain at 4 T

  2006cites this paper
• 3.0 T MR Spectroscopy

  2006cites this paper
• Signal‐to‐noise ratio and spectral linewidth improvements between 1.5 and 7 Tesla in proton echo‐planar spectroscopic imaging

  2006cites this paper
• Clinical 1h magnetic resonance spectroscopy of brain metastases at 1.5T and 3T

  2006cites this paper
• Quality Assurance and Artifacts

  2006cites this paper